79 related articles for article (PubMed ID: 20213743)
1. CDK5 phosphorylates eNOS at Ser-113 and regulates NO production.
Lee CH; Wei YW; Huang YT; Lin YT; Lee YC; Lee KH; Lu PJ
J Cell Biochem; 2010 May; 110(1):112-7. PubMed ID: 20213743
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid increases NO production via the SH-PTP1-CDK5-eNOS-Ser(116) signaling cascade in endothelial cells and mice.
Cho DH; Park JH; Joo Lee E; Jong Won K; Lee SH; Kim YH; Hwang S; Ja Kwon K; Young Shin C; Song KH; Jo I; Han SH
Free Radic Biol Med; 2014 Nov; 76():96-106. PubMed ID: 25150199
[TBL] [Abstract][Full Text] [Related]
3. Cyclin-dependent kinase 5 phosphorylates endothelial nitric oxide synthase at serine 116.
Cho DH; Seo J; Park JH; Jo C; Choi YJ; Soh JW; Jo I
Hypertension; 2010 Feb; 55(2):345-52. PubMed ID: 20048197
[TBL] [Abstract][Full Text] [Related]
4. Disruption of neuronal nitric oxide synthase dimerization contributes to the development of Alzheimer's disease: Involvement of cyclin-dependent kinase 5-mediated phosphorylation of neuronal nitric oxide synthase at Ser(293).
Kwon KJ; Park JH; Jo I; Song KH; Han JS; Park SH; Han SH; Cho DH
Neurochem Int; 2016 Oct; 99():52-61. PubMed ID: 27296112
[TBL] [Abstract][Full Text] [Related]
5. Loss of Endothelial Nitric Oxide Synthase Promotes p25 Generation and Tau Phosphorylation in a Murine Model of Alzheimer's Disease.
Austin SA; Katusic ZS
Circ Res; 2016 Oct; 119(10):1128-1134. PubMed ID: 27601478
[TBL] [Abstract][Full Text] [Related]
6. Quantitative measurement of in vivo phosphorylation states of Cdk5 activator p35 by Phos-tag SDS-PAGE.
Hosokawa T; Saito T; Asada A; Fukunaga K; Hisanaga S
Mol Cell Proteomics; 2010 Jun; 9(6):1133-43. PubMed ID: 20097924
[TBL] [Abstract][Full Text] [Related]
7. Cyclin-dependent kinase 5--a neuronal killer?
Guo Q
Sci Aging Knowledge Environ; 2003 Dec; 2003(50):pe36. PubMed ID: 14681576
[TBL] [Abstract][Full Text] [Related]
8. Far-infrared radiation acutely increases nitric oxide production by increasing Ca(2+) mobilization and Ca(2+)/calmodulin-dependent protein kinase II-mediated phosphorylation of endothelial nitric oxide synthase at serine 1179.
Park JH; Lee S; Cho DH; Park YM; Kang DH; Jo I
Biochem Biophys Res Commun; 2013 Jul; 436(4):601-6. PubMed ID: 23756809
[TBL] [Abstract][Full Text] [Related]
9. ODF1 phosphorylation by Cdk5/p35 enhances ODF1-OIP1 interaction.
Rosales JL; Sarker K; Ho N; Broniewska M; Wong P; Cheng M; van der Hoorn FA; Lee KY
Cell Physiol Biochem; 2007; 20(5):311-8. PubMed ID: 17762160
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells.
Andreozzi F; Laratta E; Procopio C; Hribal ML; Sciacqua A; Perticone M; Miele C; Perticone F; Sesti G
Mol Cell Biol; 2007 Mar; 27(6):2372-83. PubMed ID: 17242212
[TBL] [Abstract][Full Text] [Related]
11. The role of CDK5/P25 formation/inhibition in neurodegeneration.
Camins A; Verdaguer E; Folch J; Canudas AM; Pallàs M
Drug News Perspect; 2006 Oct; 19(8):453-60. PubMed ID: 17160145
[TBL] [Abstract][Full Text] [Related]
12. Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5.
Kesavapany S; Zheng YL; Amin N; Pant HC
Biotechnol J; 2007 Aug; 2(8):978-87. PubMed ID: 17526058
[TBL] [Abstract][Full Text] [Related]
13. Basal endothelial nitric oxide synthase (eNOS) phosphorylation on Ser(1177) occurs in a stable microtubule- and tubulin acetylation-dependent manner.
Giustiniani J; Couloubaly S; Baillet A; Pourci ML; Cantaloube I; Fourniat C; Paul JL; Poüs C
Exp Cell Res; 2009 Dec; 315(20):3509-20. PubMed ID: 19632222
[TBL] [Abstract][Full Text] [Related]
14. p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro.
Town T; Zolton J; Shaffner R; Schnell B; Crescentini R; Wu Y; Zeng J; DelleDonne A; Obregon D; Tan J; Mullan M
J Neurosci Res; 2002 Aug; 69(3):362-72. PubMed ID: 12125077
[TBL] [Abstract][Full Text] [Related]
15. Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells.
Lin H; Chen MC; Chiu CY; Song YM; Lin SY
J Biol Chem; 2007 Feb; 282(5):2776-84. PubMed ID: 17145757
[TBL] [Abstract][Full Text] [Related]
16. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation.
Mount PF; Kemp BE; Power DA
J Mol Cell Cardiol; 2007 Feb; 42(2):271-9. PubMed ID: 16839566
[TBL] [Abstract][Full Text] [Related]
17. Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta.
Li T; Hawkes C; Qureshi HY; Kar S; Paudel HK
Biochemistry; 2006 Mar; 45(10):3134-45. PubMed ID: 16519508
[TBL] [Abstract][Full Text] [Related]
18. Neuronal nuclear organization is controlled by cyclin-dependent kinase 5 phosphorylation of Ras Guanine nucleotide releasing factor-1.
Kesavapany S; Pareek TK; Zheng YL; Amin N; Gutkind JS; Ma W; Kulkarni AB; Grant P; Pant HC
Neurosignals; 2006-2007; 15(4):157-73. PubMed ID: 16921254
[TBL] [Abstract][Full Text] [Related]
19. Cdk5 phosphorylates PLD2 to mediate EGF-dependent insulin secretion.
Lee HY; Jung H; Jang IH; Suh PG; Ryu SH
Cell Signal; 2008 Oct; 20(10):1787-94. PubMed ID: 18625302
[TBL] [Abstract][Full Text] [Related]
20. Physiological and Pathological Roles of Cdk5: Potential Directions for Therapeutic Targeting in Neurodegenerative Disease.
Allnutt AB; Waters AK; Kesari S; Yenugonda VM
ACS Chem Neurosci; 2020 May; 11(9):1218-1230. PubMed ID: 32286796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
